|
D(2) dopamine receptor
|
PR_000001177 |
[A D(2)-like dopamine receptor that is a translation product of the human DRD2 gene or a 1:1 ortholog thereof.] |
|
butyrate metabolic process
|
GO_0019605 |
[The chemical reactions and pathways involving any butyrate, the anions of butyric acid (butanoic acid), a saturated, unbranched aliphatic acid.] |
|
short-chain fatty acid metabolic process
|
GO_0046459 |
[The chemical reactions and pathways involving a fatty acid with an aliphatic tail of less than 6 carbons.] |
|
butyrate
|
CHEBI_17968 |
[A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.] |
|
5beta steroid
|
CHEBI_136889 |
[Any steroid that has beta-configuration at position 5.] |
|
steroid
|
CHEBI_35341 |
[Any of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene which is a triterpene.] |
|
feeding behavior
|
GO_0007631 |
[Behavior associated with the intake of food.] |
|
negative regulation of translational elongation
|
GO_0045900 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of translational elongation.] |
|
positive regulation of translational elongation
|
GO_0045901 |
[Any process that activates or increases the frequency, rate or extent of translational elongation.] |
|
negative regulation of translational termination
|
GO_0045904 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of translational termination.] |
|
negative regulation of protein-containing complex disassembly
|
GO_0043242 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.] |
|
DNA catabolic process
|
GO_0006308 |
[The cellular DNA metabolic process resulting in the breakdown of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one.] |
|
DNA metabolic process
|
GO_0006259 |
[Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides.] |
|
DNA nuclease activity
|
GO_0004536 |
[Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acid.] |
|
deoxyribonucleic acid
|
CHEBI_16991 |
[High molecular weight, linear polymers, composed of nucleotides containing deoxyribose and linked by phosphodiester bonds; DNA contain the genetic information of organisms.] |
|
positive regulation of translational termination
|
GO_0045905 |
[Any process that activates or increases the frequency, rate or extent of translational termination.] |
|
positive regulation of protein-containing complex disassembly
|
GO_0043243 |
[Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.] |
|
apoptotic DNA fragmentation
|
GO_0006309 |
[The cleavage of DNA during apoptosis, which usually occurs in two stages: cleavage into fragments of about 50 kbp followed by cleavage between nucleosomes to yield 200 bp fragments.] |
|
myocardium of anterior wall of left ventricle
|
UBERON_0036290 |
|
|
left ventricle myocardium
|
UBERON_0006566 |
[A myocardium that is part of a left ventricle of a heart.] |